Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
5(19%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
1
4%
Ph phase_1
20
74%
Ph phase_2
5
19%
Ph phase_3
1
4%

Phase Distribution

21

Early Stage

5

Mid Stage

1

Late Stage

Phase Distribution27 total trials
Early Phase 1First-in-human
1(3.7%)
Phase 1Safety & dosage
20(74.1%)
Phase 2Efficacy & side effects
5(18.5%)
Phase 3Large-scale testing
1(3.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

27

all time

Status Distribution
Active(6)
Completed(5)
Other(16)

Detailed Status

unknown16
Completed5
Active, not recruiting3
Recruiting2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
27
Active
5
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (3.7%)
Phase 120 (74.1%)
Phase 25 (18.5%)
Phase 31 (3.7%)

Trials by Status

active_not_recruiting311%
not_yet_recruiting14%
completed519%
unknown1659%
recruiting27%

Recent Activity

Clinical Trials (27)

Showing 20 of 27 trialsScroll for more
NCT07441226Phase 2

Umbilical Cord Mesenchymal Stem Cells as Adjuvant Therapy in Group E COPD Patients

Recruiting
NCT04314687Phase 1

Stem Cell and Conditioned Medium for Cerebral Palsy

Active Not Recruiting
NCT05008588Phase 1

Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct

Active Not Recruiting
NCT07396155Phase 1

Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial

Recruiting
NCT06501066Phase 1

Mesenchymal Stem Cells for Frailty Syndrome

Active Not Recruiting
NCT06485648Early Phase 1

Mesenchymal Stem Cell Transfusion for the Treatment of Refractory Lupus Nephritis

Not Yet Recruiting
NCT02287831Phase 1

Umbilical Cord Mesenchymal Stem Cells Injection for Peripheral Arterial Disease

Completed
NCT05682586Phase 3

UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients

Unknown
NCT03745417Phase 1

Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe Psoriasis

Unknown
NCT02302599Phase 2

Mesenchymal Stem Cells to Treat Type 2 Diabetes

Completed
NCT04457609Phase 1

Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients

Unknown
NCT04441658Phase 1

Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Transplantation in Patients With Type 2 Diabetes Mellitus

Unknown
NCT02235844Phase 1

Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)

Completed
NCT01985464Phase 1

Umbilical Cord Tissue-derived Mesenchymal Stem Cells for Rheumatoid Arthritis

Unknown
NCT03505034Phase 2

Intrathecal Transplantation of UC-MSC in Patients With Late Stage of Chronic Spinal Cord Injury

Unknown
NCT03521323Phase 2

Intrathecal Transplantation of UC-MSC in Patients With Early Stage of Chronic Spinal Cord Injury

Unknown
NCT03521336Phase 2

Intrathecal Transplantation of UC-MSC in Patients With Sub-Acute Spinal Cord Injury

Unknown
NCT02192749Phase 1

Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Autism

Completed
NCT02034188Phase 1

Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple Sclerosis

Completed
NCT02834858Phase 1

Umbilical Cord Mesenchymal Stem Cells Infusion for Diabetes Related Vascular Complications

Unknown

Drug Details

Intervention Type
GENETIC
Total Trials
27